Cargando…
Biomarkers and their combination in a prediction of decompensation after an index hospitalization for acute heart failure
INTRODUCTION: Heart failure (HF) still remains as one of the most common causes of hospital admission with a high mortality rate. AIM: To investigate the possible prognostic role of brain natriuretic peptide (BNP), high-sensitivity (hs) cardiac troponin (cTn) I, cystatin C, and cancer antigen 125 (C...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451570/ https://www.ncbi.nlm.nih.gov/pubmed/37636186 http://dx.doi.org/10.4103/jfmpc.jfmpc_1456_22 |
_version_ | 1785095441921081344 |
---|---|
author | Durak-Nalbantic, Azra Begic, Edin Begic, Alden Dzubur, Alen Lepara, Orhan Baljic, Rusmir Hamzic-Mehmedbasic, Aida Rebic, Damir Hodzic, Enisa Halimic, Mirza Badnjevic, Almir |
author_facet | Durak-Nalbantic, Azra Begic, Edin Begic, Alden Dzubur, Alen Lepara, Orhan Baljic, Rusmir Hamzic-Mehmedbasic, Aida Rebic, Damir Hodzic, Enisa Halimic, Mirza Badnjevic, Almir |
author_sort | Durak-Nalbantic, Azra |
collection | PubMed |
description | INTRODUCTION: Heart failure (HF) still remains as one of the most common causes of hospital admission with a high mortality rate. AIM: To investigate the possible prognostic role of brain natriuretic peptide (BNP), high-sensitivity (hs) cardiac troponin (cTn) I, cystatin C, and cancer antigen 125 (CA125) in the prediction of decompensation after an index hospitalization and to investigate their possible additive prognostic value. PATIENTS AND METHODS: Two hundred twenty-two patients hospitalized with acute HF were monitored and followed for 18 months. RESULTS: BNP at discharge has the highest sensitivity and specificity in the prediction of decompensation. For a cutoff value of 423.3 pg/ml, sensitivity was 64.3% and specificity was 64.5%, with a positive predictive value of 71.6% and an area under the curve (AUC) of 0.69 (P < 0.001). The hazard risk (HR) for decompensation when the discharge BNP was above the cutoff value was 2.18. Cystatin C, at a cutoff value of 1.46 mg/L, had a sensitivity of 57% and specificity of 57.8%, with a positive predictive value of 65.8% and an AUC of 0.59 (P = 0.028). CA125, in the prediction of decompensation in patients with acute heart failure (AHF) and at a cutoff value of 80.5 IU/L, had a sensitivity of 60.5% and specificity of 53.3%, with a positive predictive value of 64.5% and an AUC of 0.59 (P = 0.022). The time till onset of decompensation was significantly shorter in patients with four versus three elevated biomarkers (P = 0.047), with five versus three elevated biomarkers (P = 0.026), and in patients with four versus two elevated biomarkers (P = 0.026). The HR for decompensation in patients with five positive biomarkers was 3.7 (P = 0.001) and in patients with four positive biomarkers was 2.5 (P = 0.014), compared to patients who had fewer positive biomarkers. CONCLUSION: BNP, cystatin C, and CA125 are predictors of decompensation, and their combined usage leads to better prediction of new decompensation. |
format | Online Article Text |
id | pubmed-10451570 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-104515702023-08-26 Biomarkers and their combination in a prediction of decompensation after an index hospitalization for acute heart failure Durak-Nalbantic, Azra Begic, Edin Begic, Alden Dzubur, Alen Lepara, Orhan Baljic, Rusmir Hamzic-Mehmedbasic, Aida Rebic, Damir Hodzic, Enisa Halimic, Mirza Badnjevic, Almir J Family Med Prim Care Original Article INTRODUCTION: Heart failure (HF) still remains as one of the most common causes of hospital admission with a high mortality rate. AIM: To investigate the possible prognostic role of brain natriuretic peptide (BNP), high-sensitivity (hs) cardiac troponin (cTn) I, cystatin C, and cancer antigen 125 (CA125) in the prediction of decompensation after an index hospitalization and to investigate their possible additive prognostic value. PATIENTS AND METHODS: Two hundred twenty-two patients hospitalized with acute HF were monitored and followed for 18 months. RESULTS: BNP at discharge has the highest sensitivity and specificity in the prediction of decompensation. For a cutoff value of 423.3 pg/ml, sensitivity was 64.3% and specificity was 64.5%, with a positive predictive value of 71.6% and an area under the curve (AUC) of 0.69 (P < 0.001). The hazard risk (HR) for decompensation when the discharge BNP was above the cutoff value was 2.18. Cystatin C, at a cutoff value of 1.46 mg/L, had a sensitivity of 57% and specificity of 57.8%, with a positive predictive value of 65.8% and an AUC of 0.59 (P = 0.028). CA125, in the prediction of decompensation in patients with acute heart failure (AHF) and at a cutoff value of 80.5 IU/L, had a sensitivity of 60.5% and specificity of 53.3%, with a positive predictive value of 64.5% and an AUC of 0.59 (P = 0.022). The time till onset of decompensation was significantly shorter in patients with four versus three elevated biomarkers (P = 0.047), with five versus three elevated biomarkers (P = 0.026), and in patients with four versus two elevated biomarkers (P = 0.026). The HR for decompensation in patients with five positive biomarkers was 3.7 (P = 0.001) and in patients with four positive biomarkers was 2.5 (P = 0.014), compared to patients who had fewer positive biomarkers. CONCLUSION: BNP, cystatin C, and CA125 are predictors of decompensation, and their combined usage leads to better prediction of new decompensation. Wolters Kluwer - Medknow 2023-06 2023-06-30 /pmc/articles/PMC10451570/ /pubmed/37636186 http://dx.doi.org/10.4103/jfmpc.jfmpc_1456_22 Text en Copyright: © 2023 Journal of Family Medicine and Primary Care https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Durak-Nalbantic, Azra Begic, Edin Begic, Alden Dzubur, Alen Lepara, Orhan Baljic, Rusmir Hamzic-Mehmedbasic, Aida Rebic, Damir Hodzic, Enisa Halimic, Mirza Badnjevic, Almir Biomarkers and their combination in a prediction of decompensation after an index hospitalization for acute heart failure |
title | Biomarkers and their combination in a prediction of decompensation after an index hospitalization for acute heart failure |
title_full | Biomarkers and their combination in a prediction of decompensation after an index hospitalization for acute heart failure |
title_fullStr | Biomarkers and their combination in a prediction of decompensation after an index hospitalization for acute heart failure |
title_full_unstemmed | Biomarkers and their combination in a prediction of decompensation after an index hospitalization for acute heart failure |
title_short | Biomarkers and their combination in a prediction of decompensation after an index hospitalization for acute heart failure |
title_sort | biomarkers and their combination in a prediction of decompensation after an index hospitalization for acute heart failure |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451570/ https://www.ncbi.nlm.nih.gov/pubmed/37636186 http://dx.doi.org/10.4103/jfmpc.jfmpc_1456_22 |
work_keys_str_mv | AT duraknalbanticazra biomarkersandtheircombinationinapredictionofdecompensationafteranindexhospitalizationforacuteheartfailure AT begicedin biomarkersandtheircombinationinapredictionofdecompensationafteranindexhospitalizationforacuteheartfailure AT begicalden biomarkersandtheircombinationinapredictionofdecompensationafteranindexhospitalizationforacuteheartfailure AT dzuburalen biomarkersandtheircombinationinapredictionofdecompensationafteranindexhospitalizationforacuteheartfailure AT leparaorhan biomarkersandtheircombinationinapredictionofdecompensationafteranindexhospitalizationforacuteheartfailure AT baljicrusmir biomarkersandtheircombinationinapredictionofdecompensationafteranindexhospitalizationforacuteheartfailure AT hamzicmehmedbasicaida biomarkersandtheircombinationinapredictionofdecompensationafteranindexhospitalizationforacuteheartfailure AT rebicdamir biomarkersandtheircombinationinapredictionofdecompensationafteranindexhospitalizationforacuteheartfailure AT hodzicenisa biomarkersandtheircombinationinapredictionofdecompensationafteranindexhospitalizationforacuteheartfailure AT halimicmirza biomarkersandtheircombinationinapredictionofdecompensationafteranindexhospitalizationforacuteheartfailure AT badnjevicalmir biomarkersandtheircombinationinapredictionofdecompensationafteranindexhospitalizationforacuteheartfailure |